Article III: Physicochemical properties of pharmaceuticals

Journal of the American Veterinary Medical Association

Volumn 213, Issue 9, 1998, Pages 1274-1277

  Martinez, Marilyn N ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; VETERINARY DRUG;

ANIMAL; AREA UNDER THE CURVE; CHEMISTRY; FEMALE; HUMAN; LIPID METABOLISM; METABOLISM; MILK; MOLECULAR WEIGHT; PH; PROTEIN BINDING; REVIEW; SOLUBILITY; TIME; UDDER;

ANIMALS; AREA UNDER CURVE; BLOOD PROTEINS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIPID METABOLISM; MAMMARY GLANDS, ANIMAL; MILK; MOLECULAR WEIGHT; PROTEIN BINDING; SOLUBILITY; TIME FACTORS; VETERINARY DRUGS;

EID: 0032209797     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Shargel L, Yu A. Applied biopharmaceutics and pharmacokinetics. 3rd ed. Norwalk, Conn: Appleton & Lange Publishers, 1993.
2. Baggot JD. Principles of drug disposition in domestic animals: the basis of veterinary clinical pharmacology. Philadelphia: WB Saunders Co, 1977.
3. Riond JL, Riviere JE. Doxycycline binding to plasma albumin of several species. J Vet Pharmacol Ther 1989;12:253-260.
4. Riond JL, Riviere JE. Allometric analysis of doxycycine pharmacokinetic parameters. J Vet Pharmacol Ther 1990;13:404-407.
5. Mattie H. Protein binding of antibiotics and antimicrobial efficacy. In: Plasma protein binding of drugs and its consequences. Ghent, Belgium: Academic Press Inc, 1991;171-177.
6. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. In: Belpaire F, Bogaert M, Tillement JP, et al, eds. Clin Pharmacokinet 1986;11:470-482.
7. Kremer JMH, Wilting J, Janssen LHM. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 1988;40:1-47.
8. Karablut N, Drusano GL. Pharmacokinetics of the quinolone antimicrobial agents. In: Hooper DC, Wolfson JS, eds. Quinolone antimicrobial agents, 2nd ed. Washington, DC: American Society for Microbiology, 1993;195-223.
9. Barre J, Didey F, Delion F, et al. Problems in therapeutic drug monitoring: free drug level monitoring. Ther Drug Monit 1988;10:133-143
10. Tozer TN. Implications of altered plasma protein binding in disease states. In: Benet LZ, Levy G, Ferraiolo BL, et al, eds. Pharmacokinetic basis for drug treatment. New York: Raven Press, 1984;173-194.
11. Bevill RF, Koritz GD, Rudawsky G, et al. Disposition of sulfadimethoxine in swine: inclusion of protein binding factors in a pharmacokinetic model. J Pharm Biopharm 1982;10:539-550.
12. Shimoda M, Kokue E, Itani M, et al. Nonlinear pharmacokinetics of IV sulphadimethoxine and its dosage regimen in pigs. Vet Q 1989;11:242-250.
13. 14C]-trimethoprim. J Vet Pharmacol Ther 1979;2:245-255.
14. Barza M. Pharmacokinetics of antibiotics. In: Sabath LD, ed. Action of antibiotics in patients. Vienna, Austria: Hans Huber Publishers, 1982; 11-39.
15. McKellar QA. Applications of pharmacokinetics in clinical practice, in Proceedings. Intl Symp Antimicrob Select 1994;12-17.
16. Brown SA. Fluoroquinolones in animal health. J Vet Pharmacol Ther 1996;19:1-14.
17. Huber WG. Aminoglycosides, macrolides, lincosamides, polymyxins, and other antibacterial drugs. In: Booth NH, McDonald LE, eds. Veterinary pharmacology and therapeutics. 6th ed. Ames, Iowa: Iowa State University Press, 1988;822-848.
18. Baggot JD. Disposition and fate of drugs in the body. In: Booth NH, McDonald LE, eds. Veterinary pharmacology and therapeutics. 6th ed. Ames, Iowa: Iowa State University Press, 1988;38-71.
19. Bevill RF. Sulfonamides. In: Booth NH, McDonald LE, eds. Veterinary pharmacology and therapeutics. 6th ed. Ames, Iowa: Iowa State University Press, 1988;785-795.
20. 1-acid glycoproteins to plasma protein binding of some basic antimicrobials in pigs. J Vet Pharmacol Ther 1996;19:176-183.
21. Ritschel WA, Hammer GV. Prediction of the volume of distribution from in vitro data and use for estimating the absolute extent of absorption. Int J Clin Pharm Therap Tox 1980;18:298-316.
22. Herman RA, Veng-Pedersen P. Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a cogeneric series. J Pharm Sci 1994;3:423-428.
23. MacDiarmid SC. The absorption of drugs from subcutaneous and intramuscular injection sites. Vet Bull 1983;3:9-23.
24. Hsie MM, Dorsey JG. Bioavailability estimation by reversed-phase liquid chromatography: high bonding density C-18 phases for modeling biopartitioning processes. Anal Chem 1995;67:48-57.
25. Gaspari F, Bonatti M. Correlation between n-octanol/water partition coefficient and liquid chromatographic retention for caffeine and its metabolites, and some structure-pharmacokinetic considerations. J Pharm Pharmacol 1987;39:252-260.
26. Ishizaki J, Yokogawa K, Nakashima E, et al. Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol-water partition coefficients. J Pharm Pharmacol 1997;49:762-767.
27. Ishizaki J, Yokogawa K, Nakashima E, et al. Relationships between hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs. J Pharm Pharmacol 1997;49:768-772.
28. Seydel JK, Schaper KJ. Quantitative structure-pharmacokinetic relationships and drug design. Pharm Therap 1982;15:131-182.
29. Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications. Philadelphia: Lea & Febiger, 1995.
30. Mayersohn M. Principles of drug absorption. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. New York: Marcel Dekker, 1979;23-85.
31. Taira K, Koga H, Kohno S. Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1993;37:1877-1881.
32. Decre D, Bergogne-Berezin E. Pharmacokinetics of quinolone with special reference to the respiratory tree. J Antimicrob Chemother 1993;31:331-343.
33. Prescott JF, Baggot JD. Antimicrobial therapy in veterinary medicine. Ames, Iowa: Iowa State University Press, 1993.